7 Dividend Stocks to Hold On Tight to for the Next Decade

In This Article:

Here are seven outstanding dividend stocks that stand out for attractive yields and solid fundamentals. They are ideal picks for a long-term investment strategy. Fundamentally, investing in long-term dividend stocks is a sharp approach to building a solid portfolio.

A portfolio that can counter market fluctuations and provide stable income over time. For instance, the first company has disciplined cost management and is making margin expansion efforts. The second company’s shift toward first-lien loans demonstrates a strategic move to increase portfolio security and stability. Similarly, the third one’s diversified investments across geographies and property types minimize risk and boost growth potential. These elements support stable cash flows and dividend payouts.

Moreover, the fourth company has sharp subscriber growth and market leadership. The fifth one has rapid expansion in its fiber business. The sixth company has a solid bottom line in new categories. Finally, the seventh company’s growth in the e-vapor market illustrates unique strategies and fundamentals that make these companies stand out. These companies hold the fundamentals that make for long-term dividend stocks: solid dividend yields, strategic growth initiatives, and diversified portfolios.

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

Pfizer (PFE)

blue Pfizer logo on the windows of a corporate building PFR stock
blue Pfizer logo on the windows of a corporate building PFR stock

Source: photobyphm / Shutterstock.com

Pfizer (NYSE:PFE), a biopharmaceutical leader, excels in cost management and margin expansion. The company’s stock yields a forward dividend yield of 5.7%. By the end of 2024, Pfizer hopes to have achieved at least $4 billion in net cost savings through its cost realignment initiative. Despite additional expenditures from the Seagen purchase, adjusted operating expenses climbed by a meager 1% in Q1 2024. Maintaining strict cost management raised profitability and solidified the bottom line. The company’s adjusted gross margin increased by 5.3% to 79.6% in the first quarter.

Moreover, in the first quarter, Pfizer returned $2.4 billion to shareholders via dividends and invested $2.5 billion in internal research. The company also paid down approximately $1.25 billion in maturing debt and monetized its Haleon stake, reducing its equity position from 32% to 23%. With a robust dividend strategy and considerable research investments, Pfizer is a top pick among long-term dividend stocks.

Oaktree Specialty Lending (OCSL)

hands at desk near laptop computer, with one hand holding a pile of hundred dollar bills. Bank stocks. stocks to buy
hands at desk near laptop computer, with one hand holding a pile of hundred dollar bills. Bank stocks. stocks to buy

Source: shutterstock.com/CC7

Oaktree Specialty Lending (NASDAQ:OCSL) focuses on first-lien loans, enhancing portfolio security and stability. Its stock is attached to a dividend yield (forward) of 12.3%. The company’s shift toward first-lien loans is the core of its growth strategy. First-lien loans represent a senior position in the capital structure. They provide greater security and a higher claim on assets in liquidation. Oaktree Specialty’s first-lien investments have increased. They expanded from 71% of the portfolio in September 2022 to 81% currently (Q2 2024).